Current status of metal stents for managing malignant ureteric obstruction

Loading...
Thumbnail Image

Date

Authors

Sountoulides, P.
Kaplan, A.
Kaufmann, O. G.
Sofikitis, N.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Bju International

Book name

Book series

Book edition

Alternative title / Subtitle

Description

Obstruction of the ureters caused by extrinsic compression from a primary tumour or retroperitoneal lymph node masses is not unusual in the course of advanced pelvic malignancies. Most of the cases are of gynaecological or gastrointestinal origin, and the situation can be aggravated by peri-ureteric fibrosis, a long-term adverse event of previous chemotherapy or radiotherapy. Undoubtedly upper urinary tract decompression and maintenance of ureteric patency, even as a palliative measure, is important in managing these patients. Options for upper tract decompression include percutaneous nephrostomy, retrograde stenting and open urinary diversion. Plastic stents have long been used for managing malignant ureteric obstruction, but their overall success remains limited. Plastic stents often fail to be placed correctly, require regular exchange, and are faced with a high incidence of encrustation and migration. For these reasons plastic stents have been unsuccessful for long-term maintenance of ureteric patency. To overcome these limitations metal stents were introduced and recently developed in an effort to ensure better long-term patency of the obstructed ureter, fewer hospital admissions for stent change and better overall quality of life. In the present review the clinical applications of different types of metal stents are discussed, with a specific focus on the latest advances and the future options for managing malignant ureteric obstruction.

Description

Keywords

Humans, Pelvic Neoplasms/*complications, Prosthesis Design, *Stents, Treatment Outcome, Ureteral Obstruction/etiology/*therapy

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/20067458
http://onlinelibrary.wiley.com/store/10.1111/j.1464-410X.2009.09140.x/asset/j.1464-410X.2009.09140.x.pdf?v=1&t=h0p89yqo&s=ccb57285cd06505cafb2319cef797801aa72abde

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By